Citius Oncology CTOR
NASDAQ CTOR
$0.74 -0.01 (-1.93%)
At close: Aug 20, 2026 · 1:47 PM UTC

Citius Oncology (CTOR) EPS (Diluted) (2023 - 2026)

Citius Oncology (CTOR) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn -0.49
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 2.07
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 0.45
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn 7.27
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn -0.10
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 1.39
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.11
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Citius Oncology 79.62 Mn 79.62 Mn 1.00 Mn -0.08

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.27
Dec 31, 2025 -0.06
Sep 30, 2025 -0.07
Jun 30, 2025 -0.08
Mar 31, 2025 -0.11
Dec 31, 2024 -0.09
Jun 30, 2024 -3.32
Mar 31, 2024 -2.02
Dec 31, 2023 -0.07
Sep 30, 2023 -0.73
Jun 30, 2023 -0.03
Mar 31, 2023 -0.06